Medical Affairs Reputations (US): Type 2 Diabetes Mellitus
|米国のメディカルアフェアーズの評価：2型糖尿病 (T2DM) Medical Affairs Reputations (US): Type 2 Diabetes Mellitus|
|出版日: 2015年09月01日||ページ情報: 英文||
当レポートでは、2型糖尿病 (T2DM) 治療薬の主要10製品に関連するメディカルアフェアーズ (MA) チームについて米国国内の医師100名を対象に調査し、もっとも重要と考えるMAによる提供内容、もっとも尊重されているMAチームと他チームとの違い、MAによる提供内容への満足度、好みの伝達手段、改善の機会などについてまとめています。
What do physicians think of U.S. Medical Affairs teams in the Type 2 Diabetes Mellitus (T2DM) sector? Who gets top marks for performance and reputation? Who fails to measure up? How is your Medical Affairs team impacting your relationship with customers?
To find out, we surveyed 100 physicians from across the country regarding ten leading T2DM products and their associated Medical Affairs teams.
What did they have to say about your team? Are you lagging or leading your competitors? Order your report now to find out.
Note that in addition to the U.S. report we offer an equivalent report for Europe. Order both and receive, at no cost, a third report clearly setting out the differences in findings between the two regions.
Medical Affairs teams in T2DM are generally well received, but physicians do have several recommendations for improvement; we provide the details.
Some Medical Affairs offerings are highly desired by physicians. Others generate much less interest. We let you know where your team might make adjustments and strengthen relationships as a result.
The products leading in the marketplace don't necessarily lead in Medical Affairs. Which teams are doing their T2DM products justice? Which might be dragging them down?
This report lets you know.